Galway, Ireland and Oceanside, CA. Palliare, a leading developer of advanced insufflation technologies, has received EU CE Mark certification under the new EU Medical Devices Regulation (MDR) for [...]

Palliare, an emerging company with the vision to become the world technology leader in advanced insufflation, today announced FDA 510(k) clearance for its new EVA5 insufflator which is purposed [...]

The EVA15 insufflator offers switchable insufflation pressures for emerging endoscopic surgery procedures.   [Oceanside, CA – January 31, 2023] Palliare, a leading developer of advanced [...]

The company’s insufflation and healthcare safety technologies will be featured at several trade shows across the country through the end of the year.   [Oceanside, CA – September 16, 2022] [...]

Annual Meeting – Connecticut Chapter of American College of Surgeons The Connecticut Chapter of the American College of Surgeons annual meeting will take place in the Trumbull Marriott [...]

Palliare announces US FDA 510(k) clearance to extend the indications of its EVA15 insufflation technology for use in endoscopic surgery   Shipments of new END-200 tubeset to commence in [...]

AFS Annual Meeting. The AFS annual meeting 2021 will now be held September 23-26. This will be IN PERSON for 2 1/2 days at the Gaylord Opryland in Nashville, TN. EAES 2021 – World Congress on [...]

Palliare is delighted to be joining as a new partner of the STEPS Engineering Your Future Programme 2021     About STEPS STEPS Engineering Your Future (STEPS EYF) is designed to inspire [...]

Company announces completion of CE Mark registration trial Palliare, an emerging company with the vision to create a safer operating room, is pleased to announce the appointment of Samantha [...]

New Group CEO and Board member appointed   07 Dec 2020 – Galway, Ireland Palliare, an emerging company with the vision to create a safer operating room, has appointed John O’Dea as Group CEO. He [...]